Fu Ying, Liu Chang, Ren Minglei, Du Tingting, Wang Yihua, Mei Fang, Cui Ligang
Department of Ultrasound, Peking University Third Hospital, No. 49 North Garden Road, Haidian District, Beijing, 100191, China.
Department of Ultrasound, The 901th Hospital of the Joint Logistics Support Force of PLA, Hefei, 230031, China.
Heliyon. 2024 May 14;10(10):e31238. doi: 10.1016/j.heliyon.2024.e31238. eCollection 2024 May 30.
The overall diagnostic value of fine-needle aspiration (FNA) is not as excellent as that of core needle biopsy (CNB). Limited research has investigated small cervical lymph nodes inaccessible to ultrasound-guided CNB due to technical challenges associated with their small size. Therefore, this study aimed to evaluate the accuracy of ultrasound-guided FNA in determining the etiology of small cervical lymph nodes.
A retrospective analysis was conducted on patients who underwent FNA between May 2018 and May 2021 at our hospital. Cytological, histopathological, and clinical follow-up data were analyzed. The diagnostic yield of FNA was assessed based on sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy calculations.
This study included 505 patients, each with a small cervical lymph node under evaluation (total number of lymph nodes: 505). The average maximal diameter of the lymph nodes was 14.6 ± 6.2 mm. According to the Sydney system, the cytology results were as follows: Category I in 26 lymph nodes (5.1 %); Category II in 269 (53.3 %); Category III in 35 (6.9 %); Category IV in 17 (3.4 %); and Category V in 158 (31.3 %). We identified 212 malignant cases (203 metastases and 9 lymphomas) and 293 benign lymph nodes. FNA achieved high sensitivity (88.8 %), specificity (99.6 %), PPV (99.4 %), NPV (91.8 %), and overall accuracy (94.8 %) in determining the etiology of small cervical lymph nodes.
FNA cytology is suitable for small lesions inaccessible by CNB and provides a diagnostic basis for implementing clinically appropriate treatment measures.
细针穿刺抽吸活检(FNA)的总体诊断价值不如粗针穿刺活检(CNB)。由于与颈部小淋巴结尺寸小相关的技术挑战,有限的研究调查了超声引导下CNB难以触及的颈部小淋巴结。因此,本研究旨在评估超声引导下FNA在确定颈部小淋巴结病因方面的准确性。
对2018年5月至2021年5月在我院接受FNA的患者进行回顾性分析。分析细胞学、组织病理学和临床随访数据。基于敏感性、特异性、阳性预测值(PPV)、阴性预测值(NPV)和准确性计算评估FNA的诊断率。
本研究纳入505例患者,每例患者均有一个待评估的颈部小淋巴结(淋巴结总数:505个)。淋巴结的平均最大直径为14.6±6.2mm。根据悉尼系统,细胞学结果如下:I类26个淋巴结(5.1%);II类269个(53.3%);III类35个(6.9%);IV类17个(3.4%);V类158个(31.3%)。我们确定了212例恶性病例(203例转移瘤和9例淋巴瘤)和293例良性淋巴结。FNA在确定颈部小淋巴结病因方面具有高敏感性(88.8%)、特异性(99.6%)、PPV(99.4%)、NPV(91.8%)和总体准确性(94.8%)。
FNA细胞学适用于CNB难以触及的小病变,并为实施临床适当的治疗措施提供诊断依据。